SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Epithelial cell states distinguish between uterine cancers
Fri December 3rd - Two epithelial cell states have been identified that can help to distinguish between types of uterine cancer, British researchers announced last night. More
COVID-19 boosters increase immunity
Fri December 3rd - Six different types of COVID-19 boosters are safe and increase immunity following vaccination with either the AstraZeneca or Pfizer-BioNTech jabs, British researchers report today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Treatment boost for bowel problem

Thursday June 27th, 2013

Patients with an incurable bowel condition have faced a postcode lottery of treatment, NHS advisers said yesterday.

This must become a thing of the past, the National Institute for Health and Care Excellence said.

Its new guidance sets out how care for patients with ulcerative colitis can be improved.

It says doctors should take time to talk to patients and their families, explaining symptoms and treatment.

NICE says the use of the right drugs and treatments means that doctors can aim to achieve remission.

Professor Mark Baker, of NICE, said: “Ulcerative Colitis is a chronic condition that can cause much distress.

"There is no cure but it is possible to control the symptoms for long periods of time, leaving those who suffer able to live life to the full as much as possible. This is demonstrated by Manchester United’s Darren Fletcher who until recently was able to play both top flight football for his club and captain the Scottish team all whilst having his ulcerative colitis symptoms controlled by medication.”

Dr Ian Arnott, a physician who leads the UK inflammatory bowel disease audit, welcomed the guidance.

He said: "The recommendation for greater dialogue with patients about the condition and the treatment options available is vital to supporting the delivery of patient-centred care.

"Ulcerative colitis is a lifelong condition and so better information about the effects of having colitis can help with the management of it and in turn potentially improve quality of life for both patients, and their families and carers.”

Tags: Gastroenterology | Internal Medicine | NHS | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES